TINDAL Drug Patent Profile
✉ Email this page to a colleague
When do Tindal patents expire, and what generic alternatives are available?
Tindal is a drug marketed by Schering and is included in one NDA.
The generic ingredient in TINDAL is acetophenazine maleate. Additional details are available on the acetophenazine maleate profile page.
Summary for TINDAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Patent Applications: | 720 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TINDAL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TINDAL
US Patents and Regulatory Information for TINDAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | TINDAL | acetophenazine maleate | TABLET;ORAL | 012254-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |